Cargando…
President's emergency plan for AIDS relief : status and assessments /
In 2013, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) will mark nearly ten years of success with an extraordinary year of achievements. None of this would have been possible without the vision and leadership of President Bush, President Obama, and the bipartisan support of Congr...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Publishers,
©2013.
|
| Colección: | Public health in the 21st century series.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF. STATUS AND ASSESSMENTS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: NINTH ANNUAL REPORT TO CONGRESSON PEPFAR; SAVING LIVES; DRIVING RESULTS WITH SCIENCE; SMART INVESTMENTS; COUNTRY OWNERSHIP; CONCLUSION; Chapter 2: THE PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR): FUNDING ISSUES AFTER A DECADE OF IMPLEMENTATION, FY2004-FY2013; SUMMARY; INTRODUCTION; EMERGING GLOBAL HIV/AIDS FUNDING TRENDS; ISSUES FOR CONGRESS; APPENDIX. SPENDING ON HIV/AIDS TREATMENT IN PEPFAR PROGRAMS.
- Chapter 3: PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF: SHIFT TOWARD PARTNER-COUNTRY TREATMENT PROGRAMS WILL REQUIRE BETTER INFORMATION ON RESULTSWHY GAO DID THIS STUDY; WHAT GAO RECOMMENDS; WHAT GAO FOUND; ABBREVIATIONS; BACKGROUND; DATA INDICATE PROGRESS IN ACHIEVING TREATMENT PROGRAM RESULTS, BUT SOME INDICATORS HAVE LIMITATIONS; PEPFAR SUPPORTS COUNTRIES' M&E SYSTEMS, BUT WEAKNESSES LIMIT THE TIMELINESS AND COMPLETENESS OF TREATMENT RESULTS DATA; CONCLUSION; RECOMMENDATIONS FOR EXECUTIVE ACTION; AGENCY COMMENTS AND OUR EVALUATION; APPENDIX I: OBJECTIVES, SCOPE, AND METHODOLOGY.
- APPENDIX II: CRITERIA FOR ASSESSING PEPFAR DIRECT SUPPORTAPPENDIX III: SUMMARY OF STUDIES; Chapter 4: PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF: PER-PATIENT COSTS HAVE DECLINED SUBSTANTIALLY, BUT BETTER COST DATA WOULD HELP EFFORTS TO EXPAND TREATMENT; WHY GAO DID THIS STUDY; WHAT GAO RECOMMENDS; WHAT GAO FOUND; ABBREVIATIONS; BACKGROUND; LOWER-PRICED ARV DRUGS, ECONOMIES OF SCALE, AND PROGRAM MATURITY HAVE HELPED REDUCE PER-PATIENT COSTS AND CONTRIBUTED TO EXPANDING TREATMENT PROGRAMS; PEPFAR COST INFORMATION SUPPORTS EFFORTS TO EXPAND COUNTRY TREATMENT PROGRAMS BUT HAS LIMITATIONS.
- USING OGAC'S BUDGETARY FORMULA, PEPFAR HAS MET THE TREATMENT SPENDING REQUIREMENT, BUT THE FORMULA DOES NOT FULLY ACCOUNT FOR ALL FUNDSCONCLUSION; RECOMMENDATIONS FOR EXECUTIVE ACTION; AGENCY COMMENTS AND OUR EVALUATION; APPENDIX I: OBJECTIVES, SCOPE, AND METHODOLOGY; APPENDIX II: PEPFAR PROGRAM AREAS, BUDGET CODES, AND BUDGETARY FORMULA FOR TREATMENT SPENDING REQUIREMENT; Chapter 5: PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF: AGENCIES CAN ENHANCE EVALUATION QUALITY, PLANNING, AND DISSEMINATION; WHY GAO DID THIS STUDY; WHAT GAO RECOMMENDS; WHAT GAO FOUND; ABBREVIATIONS; BACKGROUND.
- PEPFAR AGENCIES HAVE EVALUATED A BROAD RANGE OF PEPFAR PROGRAMS, BUT RESULTS ARE NOT FULLY SUPPORTED IN MANY EVALUATIONSPEPFAR POLICIES AND PROCEDURES DO NOT FULLY ADHERE TO AEA EVALUATION PRINCIPLES RELATING TO PLANNING, INDEPENDENCE, AND DISSEMINATION; CONCLUSION; RECOMMENDATIONS FOR EXECUTIVE ACTION; AGENCY COMMENTS; APPENDIX I: OBJECTIVES, SCOPE, AND METHODOLOGY; APPENDIX II: GAO EVALUATION DEFINITIONS AND STANDARDS; APPENDIX III: STATISTICAL COMPARISON OF PEPFAR EVALUATIONS; INDEX.